TreeWAS – Variant ID: rs35094601

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
S22.40 Multiple fractures of ribs (closed)	0.000	0.935	0.065
S22.4 Multiple fractures of ribs	0.000	0.936	0.064
S22 Fracture of rib(s), sternum and thoracic spine	0.000	0.936	0.064
S27 Injury of other and unspecified intrathoracic organs	0.000	0.940	0.060
S20-S29 Injuries to the thorax	0.000	0.941	0.059
S22.0 Fracture of thoracic vertebra	0.000	0.942	0.058
S27.1 Traumatic haemothorax	0.000	0.945	0.055
S27.2 Traumatic heamopneumothorax	0.000	0.946	0.054
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.946	0.054
S22.5 Flail chest	0.000	0.947	0.053
S27.10 Traumatic haemothorax (without open wound into thoracic cavity)	0.000	0.948	0.052
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)	0.000	0.949	0.051
S22.3 Fracture of rib	0.000	0.950	0.050
S27.0 Traumatic pneumothorax	0.000	0.951	0.049
S29 Other and unspecified injuries of thorax	0.000	0.951	0.049
T43.2 Other and unspecified antidepressants	0.047	0.953	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.047	0.953	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.047	0.953	0.000
S27.8 Injury of other specified intrathoracic organs	0.000	0.953	0.047
S22.1 Multiple fractures of thoracic spine	0.000	0.954	0.046
R22.1 Localised swelling, mass and lump, neck	0.000	0.954	0.046
S22.41 Multiple fractures of ribs (open)	0.000	0.954	0.046
S22.9 Fracture of bony thorax, part unspecified	0.000	0.954	0.046
S22.8 Fracture of other parts of bony thorax	0.000	0.954	0.046
S22.50 Flail chest (closed)	0.000	0.954	0.046
T43.0 Tricyclic and tetracyclic antidepressants	0.046	0.954	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.045	0.955	0.000
S21 Open wound of thorax	0.000	0.956	0.044
T39.0 Salicylates	0.044	0.956	0.000
S23 Dislocation, sprain and strain of joints and ligaments of thorax	0.000	0.957	0.043
S27.9 Injury of unspecified intrathoracic organ	0.000	0.957	0.043
S27.7 Multiple injuries of intrathoracic organs	0.000	0.957	0.043
S27.6 Injury of pleura	0.000	0.957	0.043
S27.5 Injury of thoracic trachea	0.000	0.957	0.043
S27.4 Injury of bronchus	0.000	0.957	0.043
S28 Crushing injury of thorax and traumatic amputation of part of thorax	0.000	0.957	0.043
S26 Injury of heart	0.000	0.957	0.043
S25 Injury of blood vessels of thorax	0.000	0.957	0.043
S24 Injury of nerves and spinal cord at thorax level	0.000	0.957	0.043
S29.9 Unspecified injury of thorax	0.000	0.957	0.043
S20 Superficial injury of thorax	0.000	0.958	0.042
T39.1 4-Aminophenol derivatives	0.042	0.958	0.000
N18.9 Chronic renal failure, unspecified	0.000	0.958	0.042
S22.01 Fracture of thoracic vertebra (open)	0.000	0.958	0.042
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.000	0.958	0.042
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.041	0.959	0.000
S20.2 Contusion of thorax	0.000	0.960	0.040
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.040	0.960	0.000
S22.30 Fracture of rib (closed)	0.000	0.960	0.040
S27.11 Traumatic haemothorax (with open wound into thoracic cavity)	0.000	0.960	0.039
N18.3 Chronic kidney disease, stage 3	0.000	0.961	0.039
S27.21 Traumatic haemopneumothorax (with open wound into thoracic cavity)	0.000	0.961	0.039
T43.6 Psychostimulants with abuse potential	0.039	0.961	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.039	0.961	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.038	0.961	0.000
S22.51 Flail chest (open)	0.000	0.962	0.038
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.038	0.962	0.000
S27.3 Other injuries of lung	0.000	0.962	0.038
S27.80 Injury of other specified intrathoracic organs (without open wound into thoracic cavity)	0.000	0.962	0.038
T45.0 Antiallergic and antiemetic drugs	0.037	0.963	0.000
S22.31 Fracture of rib (open)	0.000	0.964	0.036
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.035	0.964	0.000
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.000	0.965	0.035
S29.7 Multiple injuries of thorax	0.000	0.965	0.035
S29.0 Injury of muscle and tendon at thorax level	0.000	0.965	0.035
T50.9 Other and unspecified drugs, medicaments and biological substances	0.035	0.965	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.035	0.965	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.035	0.965	0.000
S20.4 Other superficial injuries of back wall of thorax	0.000	0.966	0.034
T43.9 Psychotropic drug, unspecified	0.034	0.966	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.034	0.966	0.000
S22.10 Multiple fractures of thoracic spine (closed)	0.000	0.966	0.034
T39.4 Antirheumatics, not elsewhere classified	0.034	0.966	0.000
T39.2 Pyrazolone derivatives	0.034	0.966	0.000
N18 Chronic renal failure	0.000	0.966	0.034
S27.81 Injury of other specified intrathoracic organs (with open wound into thoracic cavity)	0.000	0.966	0.034
S22.11 Multiple fractures of thoracic spine (open)	0.000	0.966	0.033
S29.8 Other specified injuries of thorax	0.000	0.967	0.033
S22.81 Fracture of other parts of bony thorax (open)	0.000	0.967	0.033
S22.80 Fracture of other parts of bony thorax (closed)	0.000	0.967	0.033
S22.91 Fracture of bony thorax, part unspecified (open)	0.000	0.967	0.033
S22.90 Fracture of bony thorax, part unspecified (closed)	0.000	0.967	0.033
S21.1 Open wound of front wall of thorax	0.000	0.967	0.033
T41 Poisoning by anaesthetics and therapeutic gases	0.032	0.967	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.032	0.968	0.000
S21.9 Open wound of thorax, part unspecified	0.000	0.968	0.032
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.032	0.968	0.000
S23.4 Sprain and strain of ribs and sternum	0.000	0.968	0.032
S21.8 Open wound of other parts of thorax	0.000	0.968	0.032
S21.7 Multiple open wounds of thoracic wall	0.000	0.968	0.032
S21.0 Open wound of breast	0.000	0.968	0.032
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.032	0.968	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.032	0.968	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.031	0.969	0.000
S22.2 Fracture of sternum	0.000	0.969	0.031
S23.5 Sprain and strain of other and unspecified parts of thorax	0.000	0.969	0.031
S23.3 Sprain and strain of thoracic spine	0.000	0.969	0.031
S23.2 Dislocation of other and unspecified parts of thorax	0.000	0.969	0.031
S23.1 Dislocation of thoracic vertebra	0.000	0.969	0.031
S23.0 Traumatic rupture of thoracic intervertebral disk	0.000	0.969	0.031
S27.41 Injury of bronchus (with open wound into thoracic cavity)	0.000	0.969	0.031
S27.40 Injury of bronchus (without open wound into thoracic cavity)	0.000	0.969	0.031
S27.51 Injury of thoracic trachea (with open wound into thoracic cavity)	0.000	0.969	0.031
S27.50 Injury of thoracic trachea (without open wound into thoracic cavity)	0.000	0.969	0.031
S27.61 Injury of pleura (with open wound into thoracic cavity)	0.000	0.969	0.031
S27.60 Injury of pleura (without open wound into thoracic cavity)	0.000	0.969	0.031
S27.71 Multiple injuries of intrathoracic organs (with open wound into thoracic cavity)	0.000	0.969	0.031
S27.70 Multiple injuries of intrathoracic organs (without open wound into thoracic cavity)	0.000	0.969	0.031
S27.91 Injury of unspecified intrathoracic organ (with open wound into thoracic cavity)	0.000	0.969	0.031
S27.90 Injury of unspecified intrathoracic organ (without open wound into thoracic cavity)	0.000	0.969	0.031
S24.6 Injury of unspecified nerve of thorax	0.000	0.969	0.031
S24.5 Injury of other nerves of thorax	0.000	0.969	0.031
S24.4 Injury of thoracic sympathetic nerves	0.000	0.969	0.031
S24.3 Injury of peripheral nerves of thorax	0.000	0.969	0.031
S24.2 Injury of nerve root of thoracic spine	0.000	0.969	0.031
S24.1 Other and unspecified injuries of thoracic spinal cord	0.000	0.969	0.031
S24.0 Concussion and oedema of thoracic spinal cord	0.000	0.969	0.031
S25.9 Injury of unspecified blood vessel of thorax	0.000	0.969	0.031
S25.8 Injury of other blood vessels of thorax	0.000	0.969	0.031
S25.7 Injury of multiple blood vessels of thorax	0.000	0.969	0.031
S25.5 Injury of intercostal blood vessels	0.000	0.969	0.031
S25.4 Injury of pulmonary blood vessels	0.000	0.969	0.031
S25.3 Injury of innominate or subclavian vein	0.000	0.969	0.031
S25.2 Injury of superior vena cava	0.000	0.969	0.031
S25.1 Injury of innominate or subclavian artery	0.000	0.969	0.031
S25.0 Injury of thoracic aorta	0.000	0.969	0.031
S26.9 Injury of heart, unspecified	0.000	0.969	0.031
S26.8 Other injuries of heart	0.000	0.969	0.031
S26.0 Injury of heart with haemopericardium	0.000	0.969	0.031
S28.1 Traumatic amputation of part of thorax	0.000	0.969	0.031
S28.0 Crushed chest	0.000	0.969	0.031
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.031	0.969	0.000
S20.7 Multiple superficial injuries of thorax	0.000	0.969	0.031
T42.1 Iminostilbenes	0.031	0.969	0.000
S21.2 Open wound of back wall of thorax	0.000	0.969	0.030
T46 Poisoning by agents primarily affecting the cardiovascular system	0.030	0.970	0.000
T36 Poisoning by systemic antibiotics	0.030	0.970	0.000
N18.8 Other chronic renal failure	0.000	0.971	0.029
T45.5 Anticoagulants	0.029	0.971	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.029	0.971	0.000
T45.8 Other primarily systemic and haematological agents	0.029	0.971	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.029	0.971	0.000
T45.6 Fibrinolysis-affecting drugs	0.029	0.971	0.000
T45.4 Iron and its compounds	0.029	0.971	0.000
T45.3 Enzymes, not elsewhere classified	0.029	0.971	0.000
T50.4 Drugs affecting uric acid metabolism	0.029	0.971	0.000
T45.2 Vitamins, not elsewhere classified	0.029	0.971	0.000
R22 Localised swelling, mass and lump of skin and subcutaneous tissue	0.000	0.971	0.029
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.029	0.971	0.000
S20.1 Other and unspecified superficial injuries of breast	0.000	0.972	0.028
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.028	0.972	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.028	0.972	0.000
T50.7 Analeptics and opioid receptor antagonists	0.028	0.972	0.000
T50.5 Appetite depressants	0.028	0.972	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.028	0.972	0.000
T50.1 Loop [high-ceiling] diuretics	0.028	0.972	0.000
T50.0 Mineralocorticoids and their antagonists	0.028	0.972	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.028	0.972	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.027	0.972	0.000
T42.3 Barbiturates	0.027	0.972	0.000
T42.2 Succinimides and oxazolidinediones	0.027	0.972	0.000
S27.31 Other injuries of lung (with open wound into thoracic cavity)	0.000	0.972	0.027
T50.8 Diagnostic agents	0.027	0.973	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.026	0.974	0.000
N18.2 Chronic kidney disease, stage 2	0.000	0.974	0.026
T42.0 Hydantoin derivatives	0.026	0.974	0.000
T49.9 Topical agent, unspecified	0.026	0.974	0.000
T49.8 Other topical agents	0.026	0.974	0.000
T49.7 Dental drugs, topically applied	0.026	0.974	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.026	0.974	0.000
T49.5 Ophthalmological drugs and preparations	0.026	0.974	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.026	0.974	0.000
T49.3 Emollients, demulcents and protectants	0.026	0.974	0.000
T49.2 Local astringents and local detergents	0.026	0.974	0.000
T49.1 Antipruritics	0.026	0.974	0.000
R22.0 Localised swelling, mass and lump, head	0.000	0.975	0.025
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.025	0.975	0.000
S20.3 Other superficial injuries of front wall of thorax	0.000	0.975	0.024
T43.3 Phenothiazine antipsychotics and neuroleptics	0.024	0.975	0.000
R22.9 Localised swelling, mass and lump, unspecified	0.000	0.976	0.024
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.024	0.976	0.000
R22.2 Localised swelling, mass and lump, trunk	0.000	0.976	0.024
T42.4 Benzodiazepines	0.024	0.976	0.000
S20.0 Contusion of breast	0.000	0.976	0.023
T41.5 Therapeutic gases	0.023	0.976	0.000
T41.4 Anaesthetic, unspecified	0.023	0.976	0.000
T41.3 Local anaesthetics	0.023	0.976	0.000
T41.2 Other and unspecified general anaesthetics	0.023	0.976	0.000
T41.1 Intravenous anaesthetics	0.023	0.976	0.000
T41.0 Inhaled anaesthetics	0.023	0.976	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.023	0.977	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.023	0.977	0.000
T37.5 Antiviral drugs	0.023	0.977	0.000
T37.4 Anthelminthics	0.023	0.977	0.000
T37.3 Other antiprotozoal drugs	0.023	0.977	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.023	0.977	0.000
T37.1 Antimycobacterial drugs	0.023	0.977	0.000
T37.0 Sulphonamides	0.023	0.977	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.023	0.977	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.023	0.977	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.023	0.977	0.000
T47.7 Emetics	0.023	0.977	0.000
T47.6 Antidiarrhoeal drugs	0.023	0.977	0.000
T47.5 Digestants	0.023	0.977	0.000
T47.4 Other laxatives	0.023	0.977	0.000
T47.3 Saline and osmotic laxatives	0.023	0.977	0.000
T47.2 Stimulant laxatives	0.023	0.977	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.023	0.977	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.023	0.977	0.000
T48.4 Expectorants	0.023	0.977	0.000
T48.3 Antitussives	0.023	0.977	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.023	0.977	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.023	0.977	0.000
T48.0 Oxytocic drugs	0.023	0.977	0.000
S22.21 Fracture of sternum (open)	0.000	0.977	0.022
T48.5 Anti-common-cold drugs	0.022	0.977	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.022	0.977	0.000
S27.30 Other injuries of lung (without open wound into thoracic cavity)	0.000	0.977	0.022
S26.01 Injury of heart with haemopericardium (with open wound into thoracic cavity)	0.000	0.977	0.022
S26.00 Injury of heart with haemopericardium (without open wound into thoracic cavity)	0.000	0.977	0.022
S26.81 Other injuries of heart (with open wound into thoracic cavity)	0.000	0.977	0.022
S26.80 Other injuries of heart (without open wound into thoracic cavity)	0.000	0.977	0.022
S26.91 Injury of heart, unspecified (with open wound into thoracic cavity)	0.000	0.977	0.022
S26.90 Injury of heart, unspecified (without open wound into thoracic cavity)	0.000	0.977	0.022
T47.0 Histamine H(2)-receptor antagonists	0.022	0.978	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.022	0.978	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.022	0.978	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.022	0.978	0.000
N18.1 Chronic kidney disease, stage 1	0.000	0.978	0.022
T46.8 Antivaricose drugs, including sclerosing agents	0.022	0.978	0.000
T46.7 Peripheral vasodilators	0.022	0.978	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.022	0.978	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.022	0.978	0.000
T36.9 Systemic antibiotic, unspecified	0.021	0.978	0.000
T36.8 Other systemic antibiotics	0.021	0.978	0.000
T36.7 Antifungal antibiotics, systemically used	0.021	0.978	0.000
T36.6 Rifamycins	0.021	0.978	0.000
T36.5 Aminoglycosides	0.021	0.978	0.000
T36.3 Macrolides	0.021	0.978	0.000
T36.2 Chloramphenicol group	0.021	0.978	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.021	0.978	0.000
T36.4 Tetracyclines	0.021	0.979	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.020	0.980	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.020	0.980	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.020	0.980	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.020	0.980	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.020	0.980	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.020	0.980	0.000
T44.0 Anticholinesterase agents	0.020	0.980	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.020	0.980	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.019	0.980	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.020	0.980	0.000
R22.7 Localised swelling, mass and lump, multiple sites	0.000	0.981	0.019
T36.0 Penicillins	0.019	0.981	0.000
T46.1 Calcium-channel blockers	0.019	0.981	0.000
N18.4 Chronic kidney disease, stage 4	0.000	0.981	0.019
T46.3 Coronary vasodilators, not elsewhere classified	0.018	0.982	0.000
R22.4 Localised swelling, mass and lump, lower limb	0.000	0.982	0.018
S20.8 Superficial injuries of other and unspecified parts of thorax	0.000	0.983	0.017
T38.9 Other and unspecified hormone antagonists	0.017	0.983	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.017	0.983	0.000
T38.7 Androgens and anabolic congeners	0.017	0.983	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.017	0.983	0.000
T38.5 Other oestrogens and progestogens	0.017	0.983	0.000
T38.4 Oral contraceptives	0.017	0.983	0.000
T38.2 Antithyroid drugs	0.017	0.983	0.000
T38.0 Glucocorticoids and synthetic analogues	0.017	0.983	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.016	0.984	0.000
R22.3 Localised swelling, mass and lump, upper limb	0.000	0.985	0.015
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.014	0.986	0.000
T40.8 Lysergide [LSD]	0.014	0.986	0.000
T40.7 Cannabis (derivatives)	0.014	0.986	0.000
T40.5 Cocaine	0.014	0.986	0.000
T40.3 Methadone	0.014	0.986	0.000
T40.0 Opium	0.014	0.986	0.000
T40.6 Other and unspecified narcotics	0.014	0.986	0.000
T40.1 Heroin	0.014	0.986	0.000
T38.1 Thyroid hormones and substitutes	0.014	0.986	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.012	0.987	0.000
M43.17 Spondylolisthesis (Lumbosacral region)	0.000	0.988	0.012
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.012	0.988	0.000
T40.4 Other synthetic narcotics	0.011	0.989	0.000
M43.1 Spondylolisthesis	0.000	0.989	0.011
M43.19 Spondylolisthesis (Site unspecified)	0.000	0.990	0.010
N18.5 Chronic kidney disease, stage 5	0.000	0.990	0.010
J81 Pulmonary oedema	0.000	0.990	0.010
M43.16 Spondylolisthesis (Lumbar region)	0.000	0.991	0.009
N92.0 Excessive and frequent menstruation with regular cycle	0.009	0.991	0.000
N18.0 End-stage renal disease	0.000	0.991	0.009
M43.12 Spondylolisthesis (Cervical region)	0.000	0.992	0.008
S22.20 Fracture of sternum (closed)	0.001	0.992	0.008
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)	0.000	0.992	0.008
M43.15 Spondylolisthesis (Thoracolumbar region)	0.000	0.992	0.008
M43.14 Spondylolisthesis (Thoracic region)	0.000	0.992	0.008
M43.13 Spondylolisthesis (Cervicothoracic region)	0.000	0.992	0.008
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)	0.000	0.992	0.008
M43.10 Spondylolisthesis (Multiple sites in spine)	0.000	0.992	0.008
T40.2 Other opioids	0.008	0.992	0.000
Z95.8 Presence of other cardiac and vascular implants and grafts	0.007	0.993	0.000
Z95.5 Presence of coronary angioplasty implant and graft	0.006	0.994	0.000
N49.2 Inflammatory disorders of scrotum	0.000	0.994	0.006
M23.20 Derangement of meniscus due to old tear or injury (Multiple sites)	0.006	0.994	0.000
M43 Other deforming dorsopathies	0.000	0.994	0.005
I60.9 Subarachnoid haemorrhage, unspecified	0.004	0.996	0.000
M43.0 Spondylolysis	0.000	0.996	0.004
M43.6 Torticollis	0.000	0.996	0.004
M43.9 Deforming dorsopathy, unspecified	0.000	0.996	0.004
M43.5 Other recurrent vertebral subluxation	0.000	0.996	0.004
M43.4 Other recurrent atlantoaxial subluxation	0.000	0.996	0.004
M43.3 Recurrent atlantoaxial subluxation with myelopathy	0.000	0.996	0.004
M43.2 Other fusion of spine	0.000	0.996	0.004
M43.06 Spondylolysis (Lumbar region)	0.000	0.996	0.004
M43.8 Other specified deforming dorsopathies	0.000	0.996	0.004
N87.1 Moderate cervical dysplasia	0.000	0.996	0.004
X23.9 Unspecified place	0.004	0.996	0.000
C32.0 Glottis	0.000	0.996	0.003
M43.62 Torticollis-Cervical	0.000	0.997	0.003
M43.08 Spondylolysis (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M43.07 Spondylolysis (Lumbosacral region)	0.000	0.997	0.003
M43.05 Spondylolysis (Thoracolumbar region)	0.000	0.997	0.003
M43.04 Spondylolysis (Thoracic region)	0.000	0.997	0.003
M43.03 Spondylolysis (Cervicothoracic region)	0.000	0.997	0.003
M43.01 Spondylolysis (Occipito-atlanto-axial region)	0.000	0.997	0.003
M43.00 Spondylolysis (Multiple sites in spine)	0.000	0.997	0.003
M43.69 Torticollis-Site unspe	0.000	0.997	0.003
M43.68 Torticollis-Sacral/sacrococ	0.000	0.997	0.003
M43.67 Torticollis-Lumbosacral	0.000	0.997	0.003
M43.66 Torticollis-Lumbar	0.000	0.997	0.003
M43.65 Torticollis-Thoracolumbar	0.000	0.997	0.003
M43.64 Torticollis-Thoracic	0.000	0.997	0.003
M43.63 Torticollis-Cervicothoracic	0.000	0.997	0.003
M43.61 Torticollis-Occipit-atl-axl	0.000	0.997	0.003
M43.60 Torticollis-Mult site	0.000	0.997	0.003
C92.1 Chronic myeloid leukaemia	0.000	0.997	0.003
M31.6 Other giant cell arteritis	0.003	0.997	0.000
M43.39 Recurrent atlantoaxial subluxation with myelopathy (Site unspecified)	0.000	0.997	0.003
M43.38 Recurrent atlantoaxial subluxation with myelopathy (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M43.37 Recurrent atlantoaxial subluxation with myelopathy (Lumbosacral region)	0.000	0.997	0.003
M43.36 Recurrent atlantoaxial subluxation with myelopathy (Lumbar region)	0.000	0.997	0.003
M43.35 Recurrent atlantoaxial subluxation with myelopathy (Thoracolumbar region)	0.000	0.997	0.003
M43.34 Recurrent atlantoaxial subluxation with myelopathy (Thoracic region)	0.000	0.997	0.003
M43.33 Recurrent atlantoaxial subluxation with myelopathy (Cervicothoracic region)	0.000	0.997	0.003
M43.32 Recurrent atlantoaxial subluxation with myelopathy (Cervical region)	0.000	0.997	0.003
M43.31 Recurrent atlantoaxial subluxation with myelopathy (Occipito-atlanto-axial region)	0.000	0.997	0.003
M43.30 Recurrent atlantoaxial subluxation with myelopathy (Multiple sites in spine)	0.000	0.997	0.003
M43.49 Other recurrent atlantoaxial subluxation-Site unspe	0.000	0.997	0.003
M43.48 Other recurrent atlantoaxial subluxation-Sacral/sacrococ	0.000	0.997	0.003
M43.47 Other recurrent atlantoaxial subluxation-Lumbosacral	0.000	0.997	0.003
M43.46 Other recurrent atlantoaxial subluxation-Lumbar	0.000	0.997	0.003
M43.45 Other recurrent atlantoaxial subluxation-Thoracolumbar	0.000	0.997	0.003
M43.44 Other recurrent atlantoaxial subluxation-Thoracic	0.000	0.997	0.003
M43.43 Other recurrent atlantoaxial subluxation-Cervicothoracic	0.000	0.997	0.003
M43.42 Other recurrent atlantoaxial subluxation-Cervical	0.000	0.997	0.003
M43.41 Other recurrent atlantoaxial subluxation-Occipit-atl-axl	0.000	0.997	0.003
M43.40 Other recurrent atlantoaxial subluxation-Mult site	0.000	0.997	0.003
M43.59 Other recurrent vertebral subluxation (Site unspecified)	0.000	0.997	0.003
M43.58 Other recurrent vertebral subluxation (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M43.57 Other recurrent vertebral subluxation (Lumbosacral region)	0.000	0.997	0.003
M43.56 Other recurrent vertebral subluxation (Lumbar region)	0.000	0.997	0.003
M43.55 Other recurrent vertebral subluxation (Thoracolumbar region)	0.000	0.997	0.003
M43.54 Other recurrent vertebral subluxation (Thoracic region)	0.000	0.997	0.003
M43.53 Other recurrent vertebral subluxation (Cervicothoracic region)	0.000	0.997	0.003
M43.52 Other recurrent vertebral subluxation (Cervical region)	0.000	0.997	0.003
M43.51 Other recurrent vertebral subluxation-Occipit-atl-axl	0.000	0.997	0.003
M43.50 Other recurrent vertebral subluxation (Multiple sites in spine)	0.000	0.997	0.003
M43.99 Deforming dorsopathy, unspecified (Site unspecified)	0.000	0.997	0.003
M43.98 Deforming dorsopathy, unspecified (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M43.97 Deforming dorsopathy, unspecified (Lumbosacral region)	0.000	0.997	0.003
M43.96 Deforming dorsopathy, unspecified (Lumbar region)	0.000	0.997	0.003
M43.95 Deforming dorsopathy, unspecified (Thoracolumbar region)	0.000	0.997	0.003
M43.94 Deforming dorsopathy, unspecified (Thoracic region)	0.000	0.997	0.003
M43.93 Deforming dorsopathy, unspecified (Cervicothoracic region)	0.000	0.997	0.003
M43.92 Deforming dorsopathy, unspecified (Cervical region)	0.000	0.997	0.003
M43.91 Deforming dorsopathy, unspecified (Occipito-atlanto-axial region)	0.000	0.997	0.003
M43.90 Deforming dorsopathy, unspecified (Multiple sites in spine)	0.000	0.997	0.003
C32.1 Supraglottis	0.000	0.997	0.003
M43.09 Spondylolysis (Site unspecified)	0.000	0.997	0.003
C32.9 Larynx, unspecified	0.000	0.997	0.003
C67.3 Anterior wall of bladder	0.000	0.997	0.003
C32 Malignant neoplasm of larynx	0.000	0.997	0.003
M43.28 Other fusion of spine (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M43.27 Other fusion of spine (Lumbosacral region)	0.000	0.997	0.003
M43.26 Other fusion of spine (Lumbar region)	0.000	0.997	0.003
M43.25 Other fusion of spine (Thoracolumbar region)	0.000	0.997	0.003
M43.24 Other fusion of spine (Thoracic region)	0.000	0.997	0.003
M43.23 Other fusion of spine (Cervicothoracic region)	0.000	0.997	0.003
M43.22 Other fusion of spine (Cervical region)	0.000	0.997	0.003
M43.21 Other fusion of spine (Occipito-atlanto-axial region)	0.000	0.997	0.003
M43.20 Other fusion of spine (Multiple sites in spine)	0.000	0.997	0.003
M43.89 Other specified deforming dorsopathies (Site unspecified)	0.000	0.997	0.003
M43.88 Other specified deforming dorsopathies (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M43.87 Other specified deforming dorsopathies (Lumbosacral region)	0.000	0.997	0.003
M43.85 Other specified deforming dorsopathies (Thoracolumbar region)	0.000	0.997	0.003
M43.84 Other specified deforming dorsopathies (Thoracic region)	0.000	0.997	0.003
M43.83 Other specified deforming dorsopathies (Cervicothoracic region)	0.000	0.997	0.003
M43.82 Other specified deforming dorsopathies (Cervical region)	0.000	0.997	0.003
M43.81 Other specified deforming dorsopathies (Occipito-atlanto-axial region)	0.000	0.997	0.003
M43.80 Other specified deforming dorsopathies (Multiple sites in spine)	0.000	0.997	0.003
N05.9 Unspecified	0.003	0.997	0.000
N05.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
N05 Unspecified nephritic syndrome	0.003	0.997	0.000
C43.6 Malignant melanoma of upper limb, including shoulder	0.000	0.997	0.003
M43.29 Other fusion of spine (Site unspecified)	0.000	0.997	0.003
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
J93.9 Pneumothorax, unspecified	0.003	0.997	0.000
A46 Erysipelas	0.003	0.997	0.000
M43.86 Other specified deforming dorsopathies (Lumbar region)	0.000	0.997	0.003
K92.1 Melaena	0.003	0.997	0.000
Z53.9 Procedure not carried out, unspecified reason	0.003	0.997	0.000
R91 Abnormal findings on diagnostic imaging of lung	0.003	0.997	0.000
N17-N19 Renal failure	0.000	0.997	0.003
N05.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
S72.20 Subtrochanteric fracture (closed)	0.000	0.997	0.003
K00.6 Disturbances in tooth eruption	0.000	0.997	0.003
C67.0 Trigone of bladder	0.000	0.997	0.003
N05.8 Other	0.003	0.997	0.000
N87.2 Severe cervical dysplasia, not elsewhere classified	0.000	0.997	0.003
Z97.4 Presence of external hearing-aid	0.000	0.997	0.003
C32.8 Overlapping lesion of larynx	0.000	0.997	0.002
C32.3 Laryngeal cartilage	0.000	0.997	0.002
C32.2 Subglottis	0.000	0.997	0.002
Q12.0 Congenital cataract	0.000	0.997	0.003
C67 Malignant neoplasm of bladder	0.000	0.997	0.003
N05.6 Dense deposit disease	0.002	0.997	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.997	0.000
N05.0 Minor glomerular abnormality	0.002	0.997	0.000
M43.02 Spondylolysis (Cervical region)	0.000	0.997	0.002
O20.9 Haemorrhage in early pregnancy, unspecified	0.003	0.997	0.000
C92 Myeloid leukaemia	0.000	0.997	0.003
J82 Pulmonary eosinophilia, not elsewhere classified	0.000	0.998	0.002
C92.4 Acute promyelocytic leukaemia	0.000	0.998	0.002
I36.1 Nonrheumatic tricuspid (valve) insufficiency	0.002	0.998	0.000
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.000	0.998	0.002
N02.8 Other	0.002	0.998	0.000
Z97.0 Presence of artificial eye	0.000	0.998	0.002
C67.6 Ureteric orifice	0.000	0.998	0.002
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N87 Dysplasia of cervix uteri	0.000	0.998	0.002
N87.0 Mild cervical dysplasia	0.000	0.998	0.002
N02 Recurrent and persistent haematuria	0.002	0.998	0.000
N04 Nephrotic syndrome	0.002	0.998	0.000
N04.9 Unspecified	0.002	0.998	0.000
C67.1 Dome of bladder	0.000	0.998	0.002
E10.3 With ophthalmic complications	0.000	0.998	0.002
N49 Inflammatory disorders of male genital organs, not elsewhere classified	0.000	0.998	0.002
E10.5 With peripheral circulatory complications	0.000	0.998	0.002
C92.9 Myeloid leukaemia, unspecified	0.000	0.998	0.002
X23 Contact with hornets, wasps and bees	0.002	0.998	0.000
C67.2 Lateral wall of bladder	0.000	0.998	0.002
I24.9 Acute ischaemic heart disease, unspecified	0.002	0.998	0.000
J13 Pneumonia due to Streptococcus pneumoniae	0.000	0.998	0.002
C22.1 Intrahepatic bile duct carcinoma	0.000	0.998	0.002
X23.8 Other specified place	0.002	0.998	0.000
C67.8 Overlapping lesion of bladder	0.000	0.998	0.002
C92.7 Other myeloid leukaemia	0.000	0.998	0.002
N02.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
J80-J84 Other respiratory diseases principally affecting the interstitium	0.000	0.998	0.002
N00-N08 Glomerular diseases	0.002	0.998	0.000
C67.7 Urachus	0.000	0.998	0.002
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.998	0.002
C67.5 Bladder neck	0.000	0.998	0.002
C67.4 Posterior wall of bladder	0.000	0.998	0.002
C92.0 Acute myeloid leukaemia	0.000	0.998	0.002
N05.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.998	0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.998	0.002
C92.5 Acute myelomonocytic leukaemia	0.000	0.998	0.002
C92.3 Myeloid sarcoma	0.000	0.998	0.002
C92.2 Subacute myeloid leukaemia	0.000	0.998	0.002
H16.0 Corneal ulcer	0.000	0.998	0.002
N04.2 Diffuse membranous glomerulonephritis	0.002	0.998	0.000
N04.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
Z04.1 Examination and observation following transport accident	0.000	0.998	0.002
Z71.8 Other specified counselling	0.002	0.998	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N02.6 Dense deposit disease	0.002	0.998	0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N02.1 Focal and segmental glomerular lesions	0.002	0.998	0.000
N02.0 Minor glomerular abnormality	0.002	0.998	0.000
N04.8 Other	0.002	0.998	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.002	0.998	0.000
N04.6 Dense deposit disease	0.002	0.998	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.002	0.998	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.002	0.998	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.002	0.998	0.000
N04.0 Minor glomerular abnormality	0.002	0.998	0.000
N49.9 Inflammatory disorder of unspecified male genital organ	0.000	0.998	0.002
N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens	0.000	0.998	0.002
N49.0 Inflammatory disorders of seminal vesicle	0.000	0.998	0.002
E10.2 With renal complications	0.000	0.998	0.002
M81.99 Osteoporosis, unspecified (Site unspecified)	0.000	0.998	0.002
O20 Haemorrhage in early pregnancy	0.002	0.998	0.000
D25.9 Leiomyoma of uterus, unspecified	0.002	0.998	0.000
X23.7 Farm	0.002	0.998	0.000
X23.6 Industrial and construction area	0.002	0.998	0.000
X23.5 Trade and service area	0.002	0.998	0.000
X23.4 Street and highway	0.002	0.998	0.000
X23.3 Sports and athletics area	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations